India  

Krishna Ella

Indian biotech scientist

Krishna Ella    ▸ Facts   ▸ Comments   ▸ News   ▸ Videos   

Krishna Ella is an Indian scientist and entrepreneur. He is the founder and chairman of Bharat Biotech where he is also a Managing Director. Ella and his company were responsible for developing India's own COVID-19 vaccine, Covaxin.

0
shares
ShareTweetSavePostSend
 

You Might Like


First Indian intranasal Covid vaccine to be launched on January 26

Homegrown vaccine maker Bharat Biotech will launch its intranasal Covid-19 vaccine iNCOVACC, the first of its kind in India, on January 26, the company's chairman and managing director Krishna Ella..
IndiaTimes - Published

Bharat Biotech expects regulator's nod for intranasal Covid-19 vaccine in August

Bharat Biotech, which is working on an intranasal Covid-19 vaccine candidate is hopeful of getting regulatory licenses this month, if all goes well, chairman and managing director of the company,..
IndiaTimes - Published

Bharat Biotech's Covid nasal vaccine phase 3 trials completed

The company will submit its data to the Drugs Controller General of India (DCGI) next month, said Dr Krishna Ella, Bharat Biotech chief.
DNA - Published

Search this site and the web: